Annual report pursuant to Section 13 and 15(d)

Inventories (Tables)

v3.21.2
Inventories (Tables)
12 Months Ended
May 31, 2021
Inventory Disclosure [Abstract]  
Schedule of Inventory, Current

    

May 31,

2021

2020

Raw materials

$

28,085

$

19,147

Work-in-progress

 

65,394

 

Total

$

93,479

$

19,147

Schedule of remaining shelf life of inventory

Expiration period ending May 31,

Remaining shelf-life

Raw materials

Work-in-progress bulk drug product

Work-in-progress finished drug product in vials

Total inventories

2022

0 to 12 months

$

2,684

$

-

$

-

$

2,684

2023

12 or 24 months

19,750

-

-

19,750

2024

24 to 36 months

682

-

-

682

2025

36 to 48 months

1,792

-

29,633

31,425

2026

48 to 60 months

732

-

-

732

Thereafter

60 or more months

3,140

35,761

-

38,901

Total inventories

28,780

35,761

29,633

94,174

Inventories reserved

(695)

-

-

(695)

Total inventories, net

$

28,085

$

35,761

$

29,633

$

93,479